stella
beta
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease — Stella
Recruiting
Back to No-Reflow Phenomenon trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
South Korea
Korea University Anam Hospital, Seoul
View full record on ClinicalTrials.gov